Abstract
Alpha feto-protein (AFP) is a major plasma protein produced by the yolk sac and the liver during the fetal period. During the second trimester of pregnancy, APF and βhCG serum concentrations are commonly used for screening Down syndrome. AFP deficiency is rare (estimated to be 1/105 000 newborns) and only one sequence alteration has previously been reported in the AFP gene. We report a new mutation in exon 5 of the AFP gene, leading to a total absence of AFP on 2nd-trimester maternal serum screening for Down syndrome, confirmed on the amniotic fluid. Despite this, fetal development and birth were normal. After PCR-amplification, the whole AFP gene was sequenced. The new mutation was a guanine to adenine transition in position 543 creating a premature stop codon in position 181. In order to search for eventual modifications of the amniotic fluid profile, proteins were separated by electrophoresis and compared with 10 normal amniotic fluids sampled at the same developmental age (18 weeks). In the amniotic fluid of our patient albumin rate was reduced whereas alpha1 and beta protein fractions were increased, suggesting that AFP deficiency may modify the distribution of protein fractions. This observation emphasizes the complex molecular mechanisms of compensation of serum protein deficiency. Studies on other families with AFP deficiency are necessary to confirm this observation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Heyl PS, Miller W, Canick JA : Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol. Obstet Gynecol 1990; 76: 1025–1031.
Muller F, Dreux S, Sault C et al: Very low alpha-fetoprotein in Down syndrome maternal serum screening. Prenat Diagn 2003; 23: 584–587.
Sher C, Shohat M : Congenital deficiency of AFP and Down syndrome screening. Prenat Diagn 1997; 17: 884–885.
Sharony R, Amiel A, Bouaron N, Kidron D, Itzhaky D, Fejgin M : Congenital deficiency of alpha-fetoprotein and associated chromosomal abnormality in the placenta. Am J Med Genet A 2003; 121: 113–117.
Sharony R, Zadik I, Parvari R : Congenital deficiency of alpha feto-protein. Eur J Hum Genet 2004; 12: 871–874.
Greenberg F, Faucett A, Rose E et al: Congenital deficiency of alpha-fetoprotein. Am J Obstet Gynecol 1992; 167: 509–511.
Mizejewski GJ : Levels of alpha-fetoprotein during pregnancy and early infancy in normal and disease states. Obstet Gynecol Surv 2003; 58: 804–826.
Koot BG, Houwen R, Pot DJ, Nauta J : Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. Eur J Pediatr 2004; 163: 664–670.
Tilghman SM, Belayew A : Transcriptional control of the murine albumin/alpha-fetoprotein locus during development. Proc Natl Acad Sci USA 1982; 79: 5254–5257.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petit, F., Hébert, M., Picone, O. et al. A new mutation in the AFP gene responsible for a total absence of alpha feto-protein on second trimester maternal serum screening for Down syndrome. Eur J Hum Genet 17, 387–390 (2009). https://doi.org/10.1038/ejhg.2008.186
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.186
